To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene KIF11TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
208 supporting clones for gene KIF11 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA655812   .a 1 to 457 2 to 458   tiling clone, capped   457/457
(100 %)
0 diff
(100 %id)
DA818899   .a 22 to 579 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB080343 testis .a 22 to 599 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
CN284594 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 31 to 649 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
BP233516 coronary artery .a 35 to 616 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP353489   .a 40 to 618 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
DB065167 testis .a 41 to 569 2 to 536   capped   535/535
(100 %)
6 diff
(98.9 %id)
DB212759 trachea .a 41 to 387 2 to 348   capped   347/347
(100 %)
0 diff
(100 %id)
DA461400 tongue, tumor tissue .a 44 to 619 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA511505 brain .a 47 to 625 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA736919   .a 47 to 757 2 to 710   capped   709/709
(100 %)
2 diff
(99.8 %id)
DA756554   .a 47 to 545 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
BP364466 lung .a 47 to 627 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DB083738 testis .a 48 to 586 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DB150899 thymus .a 48 to 622 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA811275 brain .a 51 to 617 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB230678 trachea .a 52 to 649 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DN995429 breast cancer, Mammary gland (cancer tissue) .a 54 to 638 8 to 592       585/592
(98 %)
6 diff
(99.0 %id)
DA438774 tongue, tumor tissue .a 56 to 648 2 to 594   capped   593/593
(100 %)
3 diff
(99.5 %id)
DA454541 tongue, tumor tissue .a 58 to 629 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BU163995 embryonal carcinoma, cell line, testis .a 72 to 865 1 to 797       797/880
(90 %)
8 diff
(99.1 %id)
BP315428 mammary gland .a 75 to 657 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA551361   .a 76 to 591 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
BP249623 Kidney .a 78 to 660 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA456373 tongue, tumor tissue .a 79 to 638 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA554744   .a 79 to 621 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB146018 thymus .a 79 to 637 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB159277 thymus .a 79 to 431 2 to 354   capped   353/353
(100 %)
1 diff
(99.8 %id)
AK314258   .a 82 to 3463 1 to 3382 E49K L412S     3382/3382
(100 %)
3 diff
(100.0 %id)
DA479265   .a 83 to 642 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
CN284601 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 94 to 673 1 to 580       580/580
(100 %)
3 diff
(99.5 %id)
DB090962 testis .a 109 to 694 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB075733 testis .a 110 to 651 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
CN284599 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 120 to 799 1 to 682       682/686
(99 %)
6 diff
(99.2 %id)
DB086734 testis .a 123 to 702 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
CN284602 embryonic stem cells, cell lines H1, H7, andH9 .a 136 to 649 1 to 515       515/515
(100 %)
9 diff
(98.3 %id)
AA857025 pharynx, squamous cell carcinoma .a 151 to 553 1 to 400     Submitted on the opposite strand 400/400
(100 %)
6 diff
(98.5 %id)
TI_1520873399   .a 178 to 838 666 to 6       661/957
(69 %)
5 diff
(99.5 %id)
TI_1959498310   .a 178 to 435 667 to 411       257/308
(83 %)
6 diff
(98.1 %id)
TI_1959499943   .a 178 to 1218 100 to 1126     Submitted on the opposite strand 1027/1248
(82 %)
18 diff
(98.6 %id)
TI_1959503009   .a 178 to 1315 98 to 1218     Submitted on the opposite strand 1121/1289
(86 %)
21 diff
(98.4 %id)
TI_1959503391   .a 178 to 1214 98 to 1122     Submitted on the opposite strand 1025/1244
(82 %)
22 diff
(98.3 %id)
BC126211 Lung, PCR rescued clones .a 185 to 4217 1 to 4032 exact     4032/4032
(100 %)
3 diff
(100.0 %id)
BC136474 Lung, PCR rescued clones .a 185 to 4214 1 to 4029 exact tiling clone,   4029/4029
(100 %)
3 diff
(100.0 %id)
TI_1520873415   .a 197 to 1122 936 to 8       929/998
(93 %)
3 diff
(99.7 %id)
CX871622 embryonic stem .a 198 to 1025 1 to 828       828/828
(100 %)
0 diff
(100 %id)
U37426   .a 203 to 5060 1 to 4858 exact tiling clone,   4858/4858
(100 %)
10 diff
(99.8 %id)
BE694443 breast .a 216 to 464 11 to 258       248/258
(96 %)
7 diff
(97.3 %id)
DA546248   .a 273 to 837 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
X85137   .a 283 to 4010 1 to 3734 E674R L675N D676S G677D F678G ...     3734/3741
(99 %)
24 diff
(99.4 %id)
TI_1959498304   .a 339 to 732 800 to 405       396/396
(100 %)
7 diff
(98.3 %id)
CN284592 embryonic stem cells, cell lines H1, H7, andH9 .a 370 to 578 424 to 632       606/632
(95 %)
6 diff
(99.1 %id)
DA483237 brain .a 370 to 799 385 to 821   capped   820/821
(99 %)
12 diff
(98.6 %id)
NM_004523.3   .a 370 to 5060 386 to 5076 exact RefSeq, AAA   5076/5076
(100 %)
0 diff
(100 %id)
DB078134 testis .a 370 to 563 386 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
TI_1520873423   .a 433 to 1503 1077 to 7       1071/1077
(99 %)
23 diff
(97.9 %id)
BP237317 coronary artery .a 582 to 1098 1 to 518       518/525
(98 %)
2 diff
(99.7 %id)
AW500376 lymph .a 599 to 911 1 to 313       313/313
(100 %)
18 diff
(94.3 %id)
AL135129 melanoma (MeWo cell line) .a 605 to 1151 1 to 548       548/548
(100 %)
2 diff
(99.7 %id)
TI_154154561   .a 605 to 1212 79 to 686       608/648
(93 %)
70 diff
(89.2 %id)
TI_154154606   .a 605 to 1260 79 to 733       655/657
(99 %)
50 diff
(92.4 %id)
TI_1959498312   .a 641 to 1103 875 to 413       463/463
(100 %)
6 diff
(98.8 %id)
BE940671 uterus_tumor .a 667 to 972 314 to 19       296/314
(94 %)
2 diff
(99.4 %id)
CF142217 lymph .a 734 to 1149 1 to 416       416/416
(100 %)
8 diff
(98.1 %id)
CF135306 lymph .a 734 to 1190 1 to 458       458/458
(100 %)
11 diff
(97.6 %id)
CF147477 lymph .a 741 to 1245 1 to 505       505/505
(100 %)
0 diff
(100 %id)
TI_154173087   .a 741 to 1304 80 to 644       565/592
(95 %)
16 diff
(97.3 %id)
TI_154185368   .a 741 to 1328 87 to 674   AAA   588/1059
(55 %)
5 diff
(99.6 %id)
AU128399   .a 962 to 1581 2 to 622   capped   621/621
(100 %)
2 diff
(99.7 %id)
TI_1959498311   .a 1083 to 1894 824 to 10       815/841
(96 %)
1 diff
(99.9 %id)
AA307194 colon .a 1109 to 1421 1 to 313       313/313
(100 %)
0 diff
(100 %id)
TI_1959501705   .a 1178 to 2398 1225 to 10       1216/1303
(93 %)
21 diff
(98.4 %id)
CN284595 embryonic stem cells, cell lines H1, H7, andH9 .a 1216 to 1884 1 to 669       669/669
(100 %)
0 diff
(100 %id)
DN913550   .a 1335 to 1697 363 to 1       363/363
(100 %)
6 diff
(98.4 %id)
BG388853 embryonal carcinoma, cell line, testis .a 1364 to 2166 1 to 806       806/1155
(69 %)
24 diff
(98.0 %id)
AW504098 lymph .a 1449 to 1910 1 to 462       462/462
(100 %)
5 diff
(99.0 %id)
TI_154160144   .a 1456 to 1998 82 to 622       541/548
(98 %)
12 diff
(97.9 %id)
BP290798 lung .a 1541 to 2094 1 to 553       553/553
(100 %)
1 diff
(99.9 %id)
CN284593 embryonic stem cells, cell lines H1, H7, andH9 .a 1587 to 2251 1 to 665       665/665
(100 %)
2 diff
(99.7 %id)
AU127456   .a 1635 to 2290 2 to 657   capped   656/671
(97 %)
9 diff
(98.7 %id)
DB092579 testis .a 1657 to 2213 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BM800579 leiomyosarcoma, uterus .a 1673 to 2574 1 to 910       910/1087
(83 %)
23 diff
(97.9 %id)
CF138561 lymph .a 1724 to 1940 8 to 224       217/224
(96 %)
16 diff
(92.9 %id)
CF138092 lymph .a 1724 to 2288 8 to 572       565/572
(98 %)
7 diff
(98.8 %id)
TI_154167920   .a 1724 to 2302 93 to 671       579/851
(68 %)
7 diff
(99.2 %id)
AU120361 whole embryo, mainly body .a 1765 to 2567 2 to 804   capped   803/804
(99 %)
10 diff
(98.8 %id)
CN284603 embryonic stem cells, DMSO-treated H9 cellline .a 1837 to 2279 1 to 443       443/443
(100 %)
0 diff
(100 %id)
BU429339 lymph .a 1850 to 2361 8 to 520       513/520
(98 %)
8 diff
(98.5 %id)
TI_154150364   .a 1850 to 2518 119 to 797       677/745
(90 %)
23 diff
(97.0 %id)
BX482200   .a 1895 to 2474 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA549801   .a 1915 to 2485 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BE790345 large cell carcinoma, lung .a 2022 to 2840 1 to 800       800/864
(92 %)
32 diff
(96.3 %id)
CN284598 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2118 to 2458 10 to 350       341/350
(97 %)
6 diff
(98.3 %id)
CX870000 embryonic stem .a 2161 to 2914 1 to 755       755/755
(100 %)
1 diff
(99.9 %id)
TI_1520873403   .a 2195 to 3215 1049 to 28       1022/1049
(97 %)
16 diff
(98.5 %id)
BG778576 adenocarcinoma, Prostate .a 2229 to 2959 1 to 748       748/748
(100 %)
34 diff
(95.5 %id)
BG118803 adenocarcinoma, cell line, Liver .a 2234 to 3020 13 to 791   AAA   779/891
(87 %)
31 diff
(96.6 %id)
AB208964 brain .a 2259 to 5060 9 to 2811       2803/2811
(99 %)
10 diff
(99.7 %id)
BI257439 cervical carcinoma cell line, cervix .a 2262 to 2914 670 to 17     Submitted on the opposite strand 654/670
(97 %)
14 diff
(98.0 %id)
TI_1959498305   .a 2336 to 3215 906 to 24       883/924
(95 %)
11 diff
(98.9 %id)
BU172266 melanotic melanoma, skin .a 2347 to 3192 1 to 852       852/858
(99 %)
9 diff
(99.0 %id)
BQ949030 leiomyosarcoma, uterus .a 2385 to 3215 1 to 839   AAA   839/1073
(78 %)
26 diff
(97.6 %id)
CA488948   .a 2387 to 3159 1 to 780       780/919
(84 %)
13 diff
(98.6 %id)
CN284596 embryonic stem cells, cell lines H1, H7, andH9 .a 2391 to 3020 1 to 630       630/630
(100 %)
5 diff
(99.3 %id)
BP237814 Liver .a 2399 to 2993 1 to 595       595/595
(100 %)
4 diff
(99.4 %id)
CD643107 Embryonic Stem cells .a 2425 to 3208 1 to 779       779/801
(97 %)
12 diff
(98.6 %id)
AU128298   .a 2475 to 3225 2 to 758   capped   757/809
(93 %)
29 diff
(96.5 %id)
AW389294 stomach .a 2480 to 2707 1 to 228       228/228
(100 %)
1 diff
(99.6 %id)
CX788535 human embryonic stem cells .a 2539 to 3361 1 to 823       823/823
(100 %)
0 diff
(100 %id)
TI_1520873419   .a 2560 to 3663 1114 to 9       1106/1194
(92 %)
19 diff
(98.5 %id)
BU173045 eye, retinoblastoma .a 2678 to 3528 1 to 861       861/871
(98 %)
15 diff
(98.3 %id)
L40372   .a 2744 to 2893 1 to 150       150/150
(100 %)
0 diff
(100 %id)
TI_1959498307   .a 2792 to 3666 881 to 7       875/885
(98 %)
6 diff
(99.4 %id)
BY997169   .a 2800 to 3425 27 to 652       626/652
(96 %)
7 diff
(99.0 %id)
BE884641 leiomyosarcoma, uterus .a 2839 to 3460 1 to 624       624/625
(99 %)
7 diff
(98.9 %id)
AL708369 human skeletal muscle .a 2843 to 3457 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BQ232200 melanotic melanoma, skin .a 2863 to 3624 1 to 771       771/905
(85 %)
12 diff
(98.7 %id)
BG388305 embryonal carcinoma, cell line, testis .a 2886 to 3674 1 to 793       793/1016
(78 %)
24 diff
(97.7 %id)
BG104639 adrenal cortex carcinoma, cell line, adrenal gland .a 2926 to 3656 1 to 724       724/880
(82 %)
24 diff
(97.3 %id)
CB116460 Liver .a 2939 to 3524 1 to 586       586/586
(100 %)
0 diff
(100 %id)
CX867424 embryonic stem .a 2942 to 3777 1 to 836       836/836
(100 %)
0 diff
(100 %id)
BP292932 lung .a 2963 to 3544 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA253721 caudate nucleus .a 2979 to 3544 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
BM803895 leiomyosarcoma, uterus .a 3000 to 3612 1 to 623       623/1489
(41 %)
16 diff
(99.0 %id)
FN078233 breast carcinoma .a 3017 to 3128 1 to 112       112/112
(100 %)
3 diff
(97.4 %id)
AU146449 whole embryo, mainly body .a 3062 to 3526 467 to 1       467/536
(87 %)
7 diff
(98.7 %id)
AI167461 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3091 to 3524 433 to 1       433/433
(100 %)
1 diff
(99.8 %id)
TI_1959498309   .a 3116 to 3906 800 to 9       792/801
(98 %)
11 diff
(98.7 %id)
BU177214 melanotic melanoma, skin .a 3205 to 3778 115 to 693       579/986
(58 %)
8 diff
(99.2 %id)
AI434705 lymph node, lymphoma, follicular mixed small and largecell .a 3209 to 3528 325 to 6       320/393
(81 %)
5 diff
(98.8 %id)
FN060514 breast carcinoma .a 3233 to 3331 1 to 100       100/101
(99 %)
4 diff
(96.1 %id)
EC439990 Prostate .a 3251 to 3350 1 to 98       98/98
(100 %)
6 diff
(93.9 %id)
BF984650 duodenal adenocarcinoma, cell line, small intestine .a 3368 to 4013 1 to 645   AAA   645/645
(100 %)
7 diff
(99.0 %id)
DB369491   .a 3392 to 3854 466 to 1       466/495
(94 %)
13 diff
(97.4 %id)
BU615394 Bone, Human Chondrosarcoma Cell Line .a 3422 to 4011 606 to 17   AAA   590/590
(100 %)
9 diff
(98.5 %id)
TI_154134052   .a 3483 to 4023 652 to 105       548/1261
(43 %)
0 diff
(100 %id)
DB364319   .a 3502 to 3841 343 to 1       343/343
(100 %)
11 diff
(96.8 %id)
BG121139 adenocarcinoma, cell line, Liver .a 3526 to 4238 10 to 720       711/939
(75 %)
31 diff
(96.7 %id)
BE542467 cervix .a 3530 to 4166 1 to 631       631/957
(65 %)
29 diff
(97.0 %id)
BQ433136 embryonal carcinoma, cell line, testis .a 3555 to 4354 1 to 811   AAA   811/888
(91 %)
18 diff
(98.0 %id)
BG256773 embryonal carcinoma, cell line, testis .a 3600 to 4440 1 to 850       850/851
(99 %)
28 diff
(96.8 %id)
AA307125 colon .a 3626 to 4146 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
AW576283 lymph .a 3651 to 4019 386 to 18   AAA   369/369
(100 %)
7 diff
(98.2 %id)
CN284600 embryonic stem cells, DMSO-treated H9 cellline .a 3742 to 4171 1 to 430       430/430
(100 %)
3 diff
(99.4 %id)
BF243861 bone marrow, from acute myelogenous leukemia .a 3756 to 4465 1 to 695       695/899
(77 %)
40 diff
(95.6 %id)
CA420070 Bone, Human Chondrosarcoma Cell Line .a 3770 to 4011 260 to 19   AAA   242/242
(100 %)
1 diff
(99.6 %id)
CU446438 epidermis .a 3774 to 4459 702 to 17   tiling clone, Submitted on the opposite strand 686/702
(97 %)
0 diff
(100 %id)
BP432554   .a 3790 to 4130 1 to 341       341/341
(100 %)
3 diff
(99.2 %id)
AA186689   .a 3828 to 4391 1 to 558       558/558
(100 %)
30 diff
(94.7 %id)
AI086253   .a 3829 to 4017 193 to 5       189/193
(97 %)
0 diff
(100 %id)
AA401791   .a 3858 to 4254 1 to 397       397/397
(100 %)
0 diff
(100 %id)
BF970409 adrenal cortex carcinoma, cell line, adrenal gland .a 3922 to 4508 1 to 591       591/595
(99 %)
11 diff
(98.2 %id)
BF212173 bone marrow, from chronic myelogenous leukemia .a 3990 to 4625 1 to 633       633/775
(81 %)
11 diff
(98.6 %id)
BF571695 melanotic melanoma, high MDR, skin .a 4071 to 4738 1 to 664       664/665
(99 %)
16 diff
(97.6 %id)
BF095170 uterus_tumor .a 4098 to 4195 8 to 106       99/106
(93 %)
9 diff
(91.6 %id)
BI047966 stomach .a 4203 to 4662 1 to 459       459/459
(100 %)
11 diff
(97.7 %id)
BI048094 stomach .a 4215 to 4740 9 to 534       526/534
(98 %)
6 diff
(98.9 %id)
BI047974 stomach .a 4216 to 4541 23 to 367       345/418
(82 %)
25 diff
(94.1 %id)
AI065110 Liver .a 4234 to 5060 1 to 832   AAA   832/832
(100 %)
8 diff
(99.1 %id)
AI867315 colon, colon tumor, RER+ .a 4234 to 4588 1 to 355     Submitted on the opposite strand 355/355
(100 %)
3 diff
(99.2 %id)
AA258374 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4243 to 4533 1 to 291     Submitted on the opposite strand 291/291
(100 %)
1 diff
(99.7 %id)
BM742618 Ascites, stomach .a 4308 to 4923 1 to 616   tiling clone,   616/616
(100 %)
0 diff
(100 %id)
TI_149308326   .a 4320 to 5060 817 to 79   AAA   739/970
(76 %)
20 diff
(98.0 %id)
CN284597 embryonic stem cells, DMSO-treated H9 cellline .a 4354 to 4767 8 to 421       414/421
(98 %)
6 diff
(98.6 %id)
CX867343 embryonic stem .a 4379 to 5027 676 to 28   AAA   649/649
(100 %)
4 diff
(99.4 %id)
AU150607   .a 4499 to 5060 556 to 1       556/574
(96 %)
12 diff
(98.0 %id)
AU150686   .a 4513 to 5060 549 to 1       549/549
(100 %)
5 diff
(99.1 %id)
AW576532 lymph .a 4759 to 5060 319 to 18   AAA   302/302
(100 %)
0 diff
(100 %id)
DN913549   .b 1 to 170 1 to 170   tiling clone,   170/170
(100 %)
5 diff
(97.1 %id)
AA504719 germinal center B cell .b 164 to 676 9 to 521   tiling clone,   513/521
(98 %)
7 diff
(98.7 %id)
BX103943 germinal center B cell .b 165 to 836 1 to 673   tiling clone,   673/673
(100 %)
3 diff
(99.6 %id)
AA504625 germinal center B cell .b 1014 to 1409 421 to 26   tiling clone, AAA   396/396
(100 %)
0 diff
(100 %id)
BC050421 Uterus, leiomyosarcoma .c 1 to 2293 1 to 2293 exact tiling clone, available from MGC, AAA   2293/2293
(100 %)
3 diff
(99.9 %id)
BQ959682 leiomyosarcoma, uterus .c 3 to 881 1 to 883 exact available from MGC,   883/884
(99 %)
12 diff
(98.7 %id)
BE018043 cervical carcinoma cell line, cervix .c 1193 to 1706 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
TI_154134378   .c 1547 to 2293 838 to 97   AAA   742/745
(99 %)
26 diff
(96.6 %id)
TI_149278121   .c 1604 to 2293 776 to 86   AAA   691/691
(100 %)
3 diff
(99.6 %id)
BU678228 lung .c 1639 to 2293 673 to 19   AAA   655/655
(100 %)
2 diff
(99.7 %id)
BE613703 leiomyosarcoma, uterus .c 1661 to 2288 1 to 623       623/623
(100 %)
13 diff
(98.0 %id)
BU687174 lung, Primary Lung Epithelial Cells .c 1729 to 2293 575 to 11   AAA   565/565
(100 %)
1 diff
(99.9 %id)
AA453158   .c 1735 to 2295 566 to 3       564/566
(99 %)
0 diff
(100 %id)
AW951006   .c 1756 to 2292 536 to 1     Submitted on the opposite strand 536/536
(100 %)
0 diff
(100 %id)
AW965747   .c 1756 to 2292 531 to 1     Submitted on the opposite strand 531/532
(99 %)
12 diff
(97.8 %id)
AW205757   .c 1762 to 2293 549 to 18   AAA   532/532
(100 %)
3 diff
(99.5 %id)
BQ212450 embryonal carcinoma, cell line, testis .c 1772 to 2260 105 to 593   AAA   489/593
(82 %)
6 diff
(99.0 %id)
AA453159   .c 1807 to 2295 495 to 4   tiling clone,   492/495
(99 %)
0 diff
(100 %id)
BM995136 Chondrosarcoma, Left Pubic Bone .c 1807 to 2293 505 to 19   AAA   487/487
(100 %)
6 diff
(98.8 %id)
AI476546 colon, moderately-differentiated adenocarcinoma .c 1836 to 2293 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AI827859 pooled .c 1836 to 2294 459 to 1       459/459
(100 %)
5 diff
(99.0 %id)
AI559454 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1864 to 2294 431 to 1       431/431
(100 %)
0 diff
(100 %id)
DB549858 hippocampus .c 1865 to 2295 1 to 431     Submitted on the opposite strand 431/435
(99 %)
5 diff
(98.9 %id)
BF439228 pooled .c 1882 to 2295 414 to 1       414/414
(100 %)
2 diff
(99.6 %id)
AI698982 adenocarcinoma, Pancreas .c 1924 to 2295 376 to 5       372/376
(98 %)
0 diff
(100 %id)
CB124978 Liver .c 1928 to 2290 1 to 363   AAA   363/363
(100 %)
1 diff
(99.8 %id)
AA471026 colon .c 1931 to 2295 367 to 3       365/367
(99 %)
0 diff
(100 %id)
AA676413   .c 1946 to 2293 348 to 1       348/348
(100 %)
0 diff
(100 %id)
AA447117   .c 1951 to 2293 343 to 1       343/343
(100 %)
0 diff
(100 %id)
AA736693 germinal center B cell .c 1980 to 2293 328 to 15   AAA   314/314
(100 %)
2 diff
(99.4 %id)
AI798275 ovary, tumor, 5 pooled (see description) .c 1988 to 2293 307 to 1       307/307
(100 %)
2 diff
(99.4 %id)
BE301453 cervical carcinoma cell line, cervix .c 1990 to 2295 310 to 5       306/310
(98 %)
0 diff
(100 %id)
AI280649 ovary, tumor, 5 pooled (see description) .c 1992 to 2293 307 to 1       307/307
(100 %)
5 diff
(98.4 %id)
AA310859   .c 2015 to 2293 279 to 1     Submitted on the opposite strand 279/279
(100 %)
1 diff
(99.7 %id)
AW821158 stomach .c 2030 to 2154 136 to 12       125/141
(88 %)
0 diff
(100 %id)
AA773541 lung, lung carcinoma .c 2197 to 2295 103 to 5       99/103
(96 %)
0 diff
(100 %id)
DA018926   .d 1 to 568 2 to 569 exact tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
BX095279 adenocarcinoma, colon .e-u 1 to 474 93 to 570   tiling clone,   478/570
(83 %)
6 diff
(99.0 %id)
AW582584 stomach .e-u 89 to 631 1 to 546 H15T K16*     546/548
(99 %)
25 diff
(95.5 %id)
AI346635 adenocarcinoma, colon .e-u 327 to 709 383 to 1 exact     383/383
(100 %)
0 diff
(100 %id)
AI281057 adenocarcinoma, colon .e-u 386 to 801 439 to 24 exact tiling clone, AAA   416/416
(100 %)
0 diff
(100 %id)
AA834391 adenocarcinoma, colon .e-u 434 to 801 367 to 1 exact     367/367
(100 %)
1 diff
(99.8 %id)
AA857639 adenocarcinoma, colon .e-u 582 to 801 220 to 1       220/220
(100 %)
3 diff
(98.7 %id)
AW609916 stomach .f 1 to 646 653 to 9 exact tiling clone,   645/662
(97 %)
9 diff
(98.7 %id)
AW360982 colon .g-u 1 to 486 485 to 5 K20R E21N L22* tiling clone,   481/511
(94 %)
0 diff
(100 %id)
BU840160 epithelioid carcinoma cell line, Pancreas .h-u 1 to 285 142 to 424 exact tiling clone, AAA   283/293
(96 %)
6 diff
(98.0 %id)
BC050667 Testis, embryonal carcinoma .h-u 32 to 276 1 to 245   tiling clone, available from MGC, AAA   245/245
(100 %)
0 diff
(100 %id)
BU170096 embryonal carcinoma, cell line, testis .h-u 33 to 276 1 to 244   available from MGC, AAA   244/244
(100 %)
0 diff
(100 %id)
TI_1520874249   Gene KIF11, variant not shown         Submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g-u, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI